Cosmos Health Valuation

COSM Stock  USD 0.48  0.01  2.13%   
Cosmos Health is undervalued. Cosmos Health shows a prevailing Real Value of $1.48 per share. The current price of the firm is $0.47999999. Our model approximates the value of Cosmos Health from analyzing the firm fundamentals such as Current Valuation of 37.7 M, return on equity of -0.64, and Profit Margin of (0.31) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cosmos Health's valuation include:
Price Book
0.7587
Enterprise Value
37.7 M
Enterprise Value Ebitda
(1.60)
Price Sales
0.3001
Forward PE
52.6316
Undervalued
Today
0.48
Please note that Cosmos Health's price fluctuation is extremely dangerous at this time. Calculation of the real value of Cosmos Health is based on 3 months time horizon. Increasing Cosmos Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cosmos stock is determined by what a typical buyer is willing to pay for full or partial control of Cosmos Health. Since Cosmos Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cosmos Stock. However, Cosmos Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.48 Real  1.48 Target  4.5 Hype  0.46 Naive  0.48
The intrinsic value of Cosmos Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cosmos Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.48
Real Value
7.46
Upside
Estimating the potential upside or downside of Cosmos Health helps investors to forecast how Cosmos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cosmos Health more accurately as focusing exclusively on Cosmos Health's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.020.466.44
Details
Naive
Forecast
LowNext ValueHigh
0.010.486.46
Details
1 Analysts
Consensus
LowTarget PriceHigh
4.104.505.00
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cosmos Health's intrinsic value based on its ongoing forecasts of Cosmos Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cosmos Health's closest peers.

Cosmos Health Cash

344,252

Cosmos Health Total Value Analysis

Cosmos Health is currently projected to have valuation of 37.7 M with market capitalization of 16.65 M, debt of 11.82 M, and cash on hands of 322.37 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cosmos Health fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
37.7 M
16.65 M
11.82 M
322.37 K

Cosmos Health Investor Information

About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.76. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cosmos Health recorded a loss per share of 0.77. The entity last dividend was issued on the 21st of November 2017. The firm had 1:10 split on the 21st of November 2017. Cosmos Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Cosmos Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cosmos Health has an asset utilization ratio of 100.21 percent. This suggests that the Company is making $1.0 for each dollar of assets. An increasing asset utilization means that Cosmos Health is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid
 
Interest Hikes

Cosmos Health Profitability Analysis

Considering the key profitability indicators obtained from Cosmos Health's historical financial statements, Cosmos Health may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Cosmos Health's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2009-09-30
Previous Quarter
-2.8 M
Current Value
-5.4 M
Quarterly Volatility
3.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
As of the 31st of January 2026, Gross Profit is likely to drop to about 4.4 M. In addition to that, Pretax Profit Margin is likely to drop to -0.28
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.08650.0911
Notably Down
Slightly volatile
For Cosmos Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cosmos Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cosmos Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cosmos Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cosmos Health over time as well as its relative position and ranking within its peers.

Cosmos Health Earnings per Share Projection vs Actual

By analyzing Cosmos Health's earnings estimates, investors can diagnose different trends across Cosmos Health's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cosmos Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Cosmos Health is projected to generate 0.0 in earnings per share on the 31st of December 2024. Cosmos Health earnings estimates show analyst consensus about projected Cosmos Health EPS (Earning Per Share). It derives the highest and the lowest estimates based on Cosmos Health's historical volatility. Many public companies, such as Cosmos Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Cosmos Health Ownership Allocation

Cosmos Health holds a total of 37.35 Million outstanding shares. Cosmos Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Cosmos Health Profitability Analysis

The company reported the previous year's revenue of 54.43 M. Net Loss for the year was (16.18 M) with profit before overhead, payroll, taxes, and interest of 6.82 M.

About Cosmos Health Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cosmos Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cosmos Health based exclusively on its fundamental and basic technical indicators. By analyzing Cosmos Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cosmos Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cosmos Health. We calculate exposure to Cosmos Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cosmos Health's related companies.
Last ReportedProjected for Next Year
Gross ProfitM4.4 M
Pretax Profit Margin(0.27)(0.28)
Operating Profit Margin(0.33)(0.31)
Net Loss(0.27)(0.28)
Gross Profit Margin 0.09  0.09 

Cosmos Health Growth Indicators

Investing in growth stocks can be very risky. If the company such as Cosmos Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding19.1 M
Forward Price Earnings52.6316

Cosmos Health Current Valuation Indicators

Cosmos Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cosmos Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cosmos Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cosmos Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cosmos Health's worth.
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.77)
Revenue Per Share
2.196
Quarterly Revenue Growth
0.379
Return On Assets
(0.13)
Return On Equity
(0.64)
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.